MG
INSM icon

Mather Group’s Insmed INSM Stock Holding History

Mather Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35K Buy
22
+13
+144% +$1.57K ﹤0.01% 1720
2026
Q1 		$1.47K Buy
+9
New +$1.38K ﹤0.01% 1733
2025
Q2 		– Sell
-70
Closed -$5.34K – 1148
2025
Q1 		$5.34K Buy
+70
New +$5.36K ﹤0.01% 1394
2024
Q3 		– Sell
-100
Closed -$2.71K – 1941
2024
Q2 		$2.71K Hold
100
– – ﹤0.01% 1804
2024
Q1 		$3.1K Buy
+100
New +$2.8K ﹤0.01% 1453

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Mather Group's INSM Position: Q2 2026 in Review

Mather Group increased its Insmed (INSM) stake by 144% in Q2 2026, buying an estimated $1.57K and bringing the position to 22 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Mather Group first reported a position in INSM in Q1 2024 and has held it in 5 quarters since. The position peaked at $5.34K in Q1 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Mather Group held 22 shares of Insmed worth $2.35K as of Q2 2026.
  • Mather Group bought 13 Insmed shares in Q2 2026, an estimated $1.57K.
  • Insmed made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1720 holding.
  • Mather Group first reported a position in Insmed in Q1 2024 and has held it in 5 quarters since.
  • Mather Group's Insmed position peaked at $5.34K in Q1 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.